Publication

Byline

Location

Singapore Clinical Trial: CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib Plus Pembrolizumab Versus Pembrolizumab And Pemetrexed And Carboplatin or Cisplatin in Patients with Previously Untreated, KRAS G12C-Mutated, Advanced Or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Singapore, May 25 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib ... और पढ़ें


Singapore Clinical Trial: A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Singapore, May 25 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durv... और पढ़ें


Singapore Clinical Trial: TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label multicenter, Phase II study to assess the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) vs standard of care in patients with progressive metastatic castrate resistant prostate cancer

Singapore, May 25 -- The Health Sciences Authority received information related to the study titled 'TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-labe... और पढ़ें


Singapore Clinical Trial: A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumour Activity of Novel Combinations in Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (LIBRA)

Singapore, May 25 -- The Health Sciences Authority received information related to the study titled 'A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety... और पढ़ें


Healthcare Income Disparities Peak in 2024 State Rankings

India, May 25 -- Median earnings for healthcare and social assistance workers across the United States show significant geographic variance in newly released 2024 data. Top Tier Earnings The Distric... और पढ़ें


California Tops National Rankings for Insured Asian Populations

India, May 25 -- Recent federal census data reveals significant geographic concentration in the total number of insured Asian residents across the United States. Coastal Coverage Leaders California ... और पढ़ें


Western States Lead 2023 Native American Health Coverage Rankings

India, May 25 -- Survey data from 2023 identifies significant disparities in health insurance enrollment for American Indian and Alaska Native populations among individual states. Western Coverage Pe... और पढ़ें


Southern States Lead in Uninsured Black Populations

India, May 25 -- Healthcare access disparities continue to manifest across the United States, with significant portions of the Black or African American population lacking health insurance coverage in... और पढ़ें


Millions of White Americans Lack Health Coverage According to 2023 Data

India, May 25 -- Recent data from the 2023 Census ACS 5 Year Survey highlights a significant health insurance crisis affecting millions of white residents across the United States. Texas and Florida ... और पढ़ें


2024 Census Data Highlights Male Health Insurance Metrics Across U.S.

India, May 25 -- Recent 2024 Census ACS 5-Year Survey data provides a detailed overview of health insurance coverage among men across the United States and its territories. California and Texas Top t... और पढ़ें